Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Stopped early

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).

Key facts

Study ID

NCT01727154

Run by

Dendreon

People needed

139

Starts

2012-10-01

Expected to finish

2017-07-01

Last updated by the study team

2019-08-19

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must be at least 18 years of age
• Subjects with prostate cancer who are enrolled in a clinical trial of sipuleucel-T (including a Dendreon-sponsored clinical trial or registry, or an IIT)
• Subjects have not yet undergone leukapheresis for their first dose of sipuleucel-T
• Subjects must understand and sign an informed consent form prior to their first leukapheresis

You may not qualify if…

• None

Where it is running

• 21st Century Oncology — Scottsdale, Arizona, United States
• Tower Urology / Tower Research Institute — Los Angeles, California, United States
• Prostate Oncology Specialists, Inc. — Marina del Rey, California, United States
• The Urology Center of Colorado — Denver, Colorado, United States
• Howard University Cancer Center — Washington D.C., District of Columbia, United States
• First Urology, PSC — Jeffersonville, Indiana, United States
• Cancer Center of Kansas — Wichita, Kansas, United States
• Tulane University — New Orleans, Louisiana, United States
• Highland Clinic — Shreveport, Louisiana, United States
• Chesapeake Urology Research Associates — Towson, Maryland, United States
• Tufts Medical Center — Boston, Massachusetts, United States
• Henry Ford Health System — Detroit, Michigan, United States
• Michigan Institute of Urology — Troy, Michigan, United States
• St. Louis Cancer Care, LLP — Bridgeton, Missouri, United States
• St. Louis Cancer Care, LLP — St Louis, Missouri, United States
• Southeast Nebraska Hematology & Oncology Consultants, P.C. d/b/a Southeast Nebraska Cancer Center — Lincoln, Nebraska, United States
• Comprehensive Cancer Centers of Nevada — Henderson, Nevada, United States
• Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada, United States
• Delaware Valley Urology, LLC — Mount Laurel, New Jersey, United States
• National Translational Research Group, Inc. — East Setauket, New York, United States
• Premier Medical Group of the Hudson Valley — Poughkeepsie, New York, United States
• Associated Medical Professionals of NY, PLLC — Syracuse, New York, United States
• Montefiore Medical Center — The Bronx, New York, United States
• Carolina Urology Partners — Gastonia, North Carolina, United States
• Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.